From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Join ShareProphets in our campaign to get LSE Bulletin Board Asylum to unban deluded Ramper QPP1000

By Tom Winnifrith | Thursday 30 October 2014


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Dreadful news for followers of the Quenron (QPP) saga – the LSE asylum has banned the most deluded ramper of all time QPP1000 from posting on its boards. We have begged the LSE to reconsider and allow this most entertaining of total nutters back in the interests both of free speech but also for sheer entertainment value.  We ask al ShareProphets readers to join us in our campaign to get QPP1000 unbanned. After all, who could forget such gems as:


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 00:15:37